Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Incidence of severe adverse events requiring hospital care after trastuzumab infusion for metastatic breast cancer: a nationwide survey using an administrative claim database.

Incidence of severe adverse events requiring hospital care after trastuzumab infusion for metastatic breast cancer: a nationwide survey using an administrative claim database. Breast J. 2011 Nov-Dec; 17(6):683-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.